WellCare Health Plans, Inc. (WCG)

Check out top investors' recommendation for WCG
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
329.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs in the United States. The company offers Medicaid plans, including plans for beneficiaries of Temporary Assistance for Needy Families (TANF) programs; Supplemental Security Income (SSI) programs; and Aged Blind and Disabled (ABD) programs; and state-based programs, such as Children’s Health Insurance Program and Family Health Plus programs for qualifying families who are not eligible for Medicaid. The TANF program provides assistance to low-income families with children; and ABD and SSI programs provide assistance to low-income aged, blind, or disabled individuals. It also provides Medicare, a federal health insurance program; Medicare Advantage, a Medicare’s managed care alternative to original Medicare that provides individuals standard Medicare benefits directly through Centers for Medicare & Medicaid Services; and coordinated care plans, which are administered through health maintenance organizations and require members to seek health care services and select a primary care physician from a network of health care providers. In addition, the company provides prescription drug plans comprising the Medicare Part D program that offers national in-network prescription drug coverage to Medicare-eligible beneficiaries. As of December 31, 2012, it served approximately 2.7 million members. WellCare Health Plans, Inc. was founded in 1985 and is headquartered in Tampa, Florida.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Steven Halper Lazard Capital Markets Buy   Sep 16, '18     330.00  Sep 16, '19  N/A 
Matthew Borsch Goldman Sachs Buy   Sep 14, '18     345.00  Sep 14, '19  N/A 
David Toung Argus Research Company Buy   Aug 31, '18     360.00  Aug 31, '19  N/A 
John Staszak Argus Research Company Buy   Aug 31, '18     360.00  Aug 31, '19  N/A 
Peter Costa Wells Fargo Securities, Llc Buy   Jul 31, '18       Jul 31, '19  N/A 
Steven Halper Lazard Capital Markets Buy   Jul 31, '18     292.00  Jul 31, '19  N/A 
Gary Taylor Citi Buy   Jun 27, '18     287.00  Jun 27, '19  N/A 
John Staszak Argus Research Company Buy   Jun 07, '18     265.00  Jun 07, '19  N/A 
Peter Costa Wells Fargo Securities, Llc Buy   May 30, '18     250.00  May 30, '19  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   May 30, '18     300.00  May 30, '19  N/A 
Sarah James Wedbush Securities Inc. Buy   May 30, '18     235.00  May 30, '19  N/A 
Steven Halper Lazard Capital Markets Buy   May 29, '18     235.00  May 29, '19  N/A 
Peter Costa Wells Fargo Securities, Llc Buy   Mar 21, '18     220.00  Mar 21, '19  N/A 
Kevin Fischbeck BofA Merrill Lynch Buy   Mar 16, '18       Mar 16, '19  N/A 
Steven Halper Lazard Capital Markets Buy   Feb 06, '18     235.00  Feb 06, '19  N/A 
Christine Arnold Cowen And Company Buy   Jan 23, '18     250.00  Jan 23, '19  N/A 
Steven Halper Lazard Capital Markets Buy   Dec 18, '17     235.00  Dec 18, '18  N/A 
Sarah James Wedbush Securities Inc. Buy   Oct 31, '17     214.00  Oct 31, '18  N/A 
Steven Halper Lazard Capital Markets Buy   Oct 31, '17     217.00  Oct 31, '18  N/A 
Christine Arnold Cowen And Company Buy   Oct 09, '17     200.00  Oct 09, '18  N/A 
< previous12